AGIO
Agios Pharm
NASDAQ: AGIO · HEALTHCARE · BIOTECHNOLOGY
$28.05
+13.10% today
Updated 2026-04-29
Market cap
$1.67B
P/E ratio
—
P/S ratio
30.88x
EPS (TTM)
$-7.26
Dividend yield
—
52W range
$22 – $46
Volume
1.1M
Agios Pharm (AGIO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.84M | $25.11M | $25.55M | $65.36M | $59.12M | $69.89M | $43.01M | $94.39M | $117.91M | $203.20M | $41409.00 | $14.24M | $26.82M | $36.50M | $54.03M |
| Revenue growth (YoY) | — | +15.0% | +1.8% | +155.8% | -9.5% | +18.2% | -38.5% | +119.4% | +24.9% | +72.3% | -100.0% | +34288.7% | +88.4% | +36.1% | +48.0% |
| Cost of revenue | $37.67M | $41.04M | $62.99M | $118.12M | $141.83M | $220.16M | $292.68M | $1.40M | $1.32M | $18.77M | $18.78M | $1.70M | $9.50M | $4.17M | $6.34M |
| Gross profit | $21.84M | $-15.93M | $25.55M | $65.36M | $59.12M | $69.89M | $43.01M | $92.99M | $116.59M | $-18.77M | $-18.78M | $12.54M | $17.32M | $32.33M | $47.68M |
| Gross margin | 100.0% | -63.5% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 98.5% | 98.9% | -9.2% | -45345.2% | 88.0% | 64.6% | 88.6% | 88.3% |
| R&D | $31.25M | $41.04M | $54.50M | $100.37M | $141.83M | $220.16M | $292.68M | $341.32M | $410.89M | $211.02M | $256.97M | $279.91M | $288.90M | $301.29M | $339.54M |
| SG&A | $7.21M | $7.06M | $9.93M | $19.12M | $35.99M | $50.71M | $71.12M | $114.14M | $132.03M | $149.07M | $121.44M | $121.67M | $119.90M | $156.78M | $180.28M |
| Operating income | $-16.63M | $-23.00M | $-38.88M | $-54.13M | $-118.70M | $-200.99M | $-320.79M | $-362.48M | $-426.33M | $-335.92M | $-378.42M | $-389.05M | $-391.49M | $-425.74M | $-472.13M |
| Operating margin | -76.2% | -91.6% | -152.2% | -82.8% | -200.8% | -287.6% | -745.8% | -384.0% | -361.6% | -165.3% | -913854.5% | -2732.1% | -1459.5% | -1166.5% | -873.9% |
| EBITDA | $-15.83M | $-21.82M | $-37.44M | $-52.77M | $-115.36M | $-195.28M | $-314.36M | $-355.31M | $-394.85M | $-310.53M | $-337.73M | $-380.48M | $-384.86M | $-420.08M | $-466.95M |
| EBITDA margin | -72.5% | -86.9% | -146.6% | -80.7% | -195.1% | -279.4% | -730.9% | -376.4% | -334.9% | -152.8% | -815602.9% | -2671.9% | -1434.8% | -1151.0% | -864.3% |
| EBIT | $-16.63M | $-23.00M | $-38.88M | $-54.13M | $-118.70M | $-200.99M | $-320.79M | $-362.48M | $-411.47M | $-329.31M | $-356.51M | $-389.05M | $-391.49M | $-425.74M | $-472.13M |
| Interest expense | $132000.00 | $69000.00 | $55000.00 | $203000.00 | $968000.00 | $2.51M | $6.12M | $16.45M | $14.86M | $17.83M | $836000.00 | $12.79M | — | — | — |
| Income tax | $7.21M | $-2.82M | $579000.00 | $-426000.00 | $-426000.00 | $-5.71M | $-6.43M | $32.90M | $-14.86M | $7.85M | $-1.98B | $-157.25M | $6.46M | $44.24M | $-1.02M |
| Effective tax rate | -43.7% | 12.3% | -1.5% | 0.8% | 0.4% | 2.8% | 2.0% | -10.5% | 3.5% | -2.5% | 530.0% | 40.4% | -1.9% | 6.2% | 0.2% |
| Net income | $-23.71M | $-20.10M | $-39.41M | $-53.50M | $-117.73M | $-198.47M | $-314.67M | $-346.03M | $-411.47M | $-327.37M | $1.60B | $-231.80M | $-352.09M | $673.73M | $-412.78M |
| Net income growth (YoY) | — | +15.2% | -96.0% | -35.8% | -120.0% | -68.6% | -58.5% | -10.0% | -18.9% | +20.4% | +590.2% | -114.4% | -51.9% | +291.4% | -161.3% |
| Profit margin | -108.6% | -80.1% | -154.2% | -81.9% | -199.1% | -284.0% | -731.6% | -366.6% | -349.0% | -161.1% | 3875280.7% | -1627.8% | -1312.6% | 1845.9% | -764.0% |